The 2020 CIPA Life Sciences Webinar Series
Friday 20th November 2020
Topic: Update from the US
Date: Friday 20th November, 2020
Time: 4:00pm - 5:15pm GMT
Agenda to Include:
Presentation on US Case law followed by a panel discussion including Dir Iancu.
US Case law update
Seth Levy, Nixon Peabody
Seth is an intellectual property partner in the firm’s Los Angeles office and co-chair of its life sciences group. He focuses his practice on IP protection, licensing, strategy, and disputes, as well as research transactions and operations, particularly in life sciences and health care. Seth works with clients to implement strategies for international IP protection and enforcement, to structure business relationships around the development and commercialization of life sciences technologies, and to support clinical research programs for both nonprofit and for-profit clients. Seth has unique experience working with academic and healthcare institutions to develop and support their technology transfer programs, and is among the few IP attorneys to have led a comprehensive patent licensing and litigation campaign to directly enforce university IP rights. He also acts as outside general counsel to emerging growth companies, including those that do business with academic and healthcare institutions.
Seth is a graduate of Cornell University with a B.S. in agricultural and biological engineering, and earned his J.D. from the University of Southern California Law School. Seth regularly presents both nationally and internationally on emerging IP issues, and he has received numerous awards and recognitions for his leadership and work in the life sciences, IP and public interest communities.
Dir. Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO
In his role as the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO), Mr. Andrei Iancu provides leadership to one of the largest Intellectual Property offices in the world, with more than 12,000 employees and an annual budget of over $3.5 billion. He also serves as the principal advisor to the President, through the Secretary of Commerce, on domestic and international intellectual property policy matters.
Prior to joining the USPTO, Mr. Iancu was the Managing Partner at Irell & Manella LLP, where his practice focused on intellectual property litigation. Mr. Iancu has also taught patent law at the UCLA School of Law, and has written and spoken publicly on a variety of intellectual property issues. Prior to his legal career, Mr. Iancu was an engineer at Hughes Aircraft Company. Mr. Iancu holds a J.D. from the UCLA School of Law, a M.S. in Mechanical Engineering and a B.S. in Aerospace Engineering, both from UCLA.
Dev Crease, Keltie LLP
Dev is a partner at Keltie LLP and works in the life science field. He represents biotech and chemicals clients based in the UK, Europe, and US. He has a PhD in developmental biology from the University of Cambridge.
Dev joined the patent profession in the late 1990s at the time of the first biotech boom. Since joining Keltie in 2004 he has developed a thriving international practice specialising in providing strategic advice and support for spin-outs and start-ups particularly in the fields of genomics, epigenetics, industrial biotechnology, synthetic biology, bioinformatics and medical devices. Dev enjoys working with companies in emerging new technologies and has helped several clients through serial funding rounds including IPOs on the London Stock Exchange as well as NASDAQ.